By proceeding, you agree to our Terms of Use and Privacy Policy.
David Brower joined Accent in September 2018 and serves as Senior Vice President of Business Development & Portfolio Strategy. David has held a number of life science business development, strategy, and investing roles prior to joining Accent.
Talks About #Biotechnology #BusinessDevelopment
Preferred Locations #NorthAmerica
Expanding & Maximizing RNA Druggability with Small Molecules As one of the most anticipated events on the RNA calendar, the RNA-Targeted Drug Discovery Summit returns for its fifth year this December.